Back
Arcutis Biotherapeutics Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.82
Seasonality Move:
47.83%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Arcutis Biotherapeutics Price Quote
$10.82
Arcutis Biotherapeutics Key Stats
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Day range:
$10.35 - $11.44
52-week range:
$1.76 - $13.17
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.89
P/B ratio:
8.08%
Volume:
4M
Avg. volume:
2M
1-year change:
391.82%
Market cap:
$1.3B
Revenue:
$59.6M
EPS:
$-1.79
How Much Does Arcutis Biotherapeutics Make?
-
How Much Are Arcutis Biotherapeutics's Sales Annually?
ARQT Revenues are $59.6M -
How Much Profit Does Arcutis Biotherapeutics's Make A Year?
ARQT net income is -$262.1M
Is Arcutis Biotherapeutics Growing As A Company?
-
What Is Arcutis Biotherapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.17% -
What Is Arcutis Biotherapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcutis Biotherapeutics Stock Price Performance
-
Did Arcutis Biotherapeutics Stock Go Up Last Month?
Arcutis Biotherapeutics share price went up by 11.78% last month -
Did ARQT's Share Price Rise Over The Last Year?
ARQT share price rose by 391.82% over the past 1 year
What Is Arcutis Biotherapeutics 52-Week High & Low?
-
What Is Arcutis Biotherapeutics’s 52-Week High Share Price?
Arcutis Biotherapeutics has traded as high as $13.17 over the past 52 weeks -
What Is Arcutis Biotherapeutics’s 52-Week Low Share Price?
Arcutis Biotherapeutics has traded as low as $1.76 over the past 52 weeks
Arcutis Biotherapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Arcutis Biotherapeutics?
-
How Much Debt Does Arcutis Biotherapeutics Have?
Total long term debt quarterly is $204.6M -
How Much Cash Does Arcutis Biotherapeutics Have?
Cash and short term investments quarterly total is $330.6M -
What Is Arcutis Biotherapeutics’s Book Value Per Share?
Book value per share is 1.34
Is Arcutis Biotherapeutics Cash Flow Positive?
-
What Is ARQT Cash Flow From Operations?
Cash flow from operations (TTM) is -$167.7M -
What Is Arcutis Biotherapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $262.9M -
What Is Arcutis Biotherapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$68.2M
Arcutis Biotherapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ARQT return on invested capital is -56.93% -
What Is Arcutis Biotherapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -49.01% -
What Is ARQT Return On Equity?
ROE is a measure of profitability and is -138.99%
Arcutis Biotherapeutics Earnings Date & Stock Price
-
What Is Arcutis Biotherapeutics's Stock Price Today?
A single share of ARQT can be purchased today for 10.82 -
What Is Arcutis Biotherapeutics’s Stock Symbol?
Arcutis Biotherapeutics trades on the nasdaq under the ticker symbol: ARQT -
When Is Arcutis Biotherapeutics’s Next Earnings Date?
The next quarterly earnings date for Arcutis Biotherapeutics is scheduled on February 27, 2025 -
When Is ARQT's next ex-dividend date?
Arcutis Biotherapeutics's next ex-dividend date is November 10, 2024 -
How To Buy Arcutis Biotherapeutics Stock?
You can buy Arcutis Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcutis Biotherapeutics Competitors
-
Who Are Arcutis Biotherapeutics's Competitors?
Below is a list of companies who compete with Arcutis Biotherapeutics or are related in some way:
Arcutis Biotherapeutics Dividend Yield
-
What Is ARQT Dividend Yield?
Arcutis Biotherapeutics’s dividend yield currently is 0% -
What Is Arcutis Biotherapeutics’s Payout Ratio?
Arcutis Biotherapeutics’s payout ratio is 0% -
When Did Arcutis Biotherapeutics Last Pay A Dividend?
The latest dividend pay date is November 10, 2024 -
What Is Arcutis Biotherapeutics’s Dividend Per Share?
Arcutis Biotherapeutics pays a dividend of $0.00 per share
Arcutis Biotherapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 22.35% |
| Revenue: | 17.44% | 19.86% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 19.00 |
| Upside from Last Price: | 75.6% |